Intracellular formation and cell surface expression of a complex of an intact lysosomal protein and MHC class II molecules

Journal of Immunology

Volumn 160, Issue 12, 1998, Pages 5797-5806

  Arunachalam, Balasubramanian ^a   Pan, Mary ^a   Cresswell, Peter ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLELE; ANIMAL CELL; ARTICLE; CELL COMPARTMENTALIZATION; COMPLEX FORMATION; ENDOCYTOSIS; LYMPHOBLASTOID CELL; LYSOSOME MEMBRANE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DENATURATION; PROTEIN LOCALIZATION; STEM CELL;

ALLELES; ANIMALS; CELL TRANSFORMATION, VIRAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HERPESVIRUS 4, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-D ANTIGENS; HLA-DR ANTIGENS; LYSOSOMES; MICE; OXIDOREDUCTASES; PROTEINS; RABBITS; SODIUM DODECYL SULFATE; SURFACE PROPERTIES;

EID: 0032526880     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Cress well, P. 1994. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12:259.
2. Busch, R., I. Cloutier, R. P. Sekaly, and G. J. Hammerling. 1996. Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum. EMBO J. 15:418.
3. Bakke, O., and B. Dobberstein. 1990. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 63:707.
4. Riberdy, J. M., J. R. Newcomb, M. J. Surman, J. A. Barbosa, and P. Cresswell. 1992. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature 360:474.
5. Denzin, L. K., and P. Cresswell. 1995. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 82:155.
6. Sherman, M. A., D. A. Weber, and P. E. Jensen. 1995. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 3:197.
7. Sloan, V. S., P. Cameron, G. Porter, M. Gammon, M. Amaya, E. Mellins, and D. M. Zaller. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR molecules. Nature 375:802.
8. Rudensky, A., P. Preston-Hurlburt, S.-C. Hong, A. Barlow, and C. J. Janeway. 1991. Sequence analysis of peptides bound to MHC class II molecules. Nature 353:622.
9. Chicz, R. M., R. G. Urban, J. C. Gorga, W. S. Lane, L. J. Stern, D. A. A. Vignali, and J. L. Strominger. 1992. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358:764.
10. d. Science 256:1817.
11. Peters, P. J., J. J. Neefjes, V. Oorschot, H. L. Ploegh, and H. J. Geuze. 1991. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 349:669.
12. Calafat, J., M. Nijenhuis, H. Janssen, A. Tulp, S. Dusseljee, R. Wubbolts, and J. Neefjes. 1994. Major histocompatibility complex class II molecules induce the formation of endocytic MIIC-like structures. J. Cell Biol. 126:967.
13. Tulp, A., D. Verwoerd, B. Dobberstein, H. L. Ploegh, and J. Pieters. 1994. Isolation and characterization of the intracellular MHC class II compartment. Nature 369:120.
14. West, M. A., J. M. Lucocq, and C. Watts. 1994. Antigen processing and class II MHC pep tide-loading compartments in human B-lymphoblastoid cells. Nature 369:147.
15. DeNagel, D. C., and S. K. Pierce. 1992. A case for chaperones in antigen processing. Immunol. Today 13:86.
16. Davidson, H. W., P. A. Reid, A. Lanzavecchia, and C. Watts. 1991. Processed antigen binds to newly synthesized MHC class II molecules in antigen-specific B lymphocytes. Cell 67:105.
17. Jensen, P. E. 1995. Antigen unfolding and disulfide reduction in antigen presenting cells. Semin. Immunol. 7:347.
18. Watts, C. 1997. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 15:821.
19. Brown, J. H., T. S. Jardetzky, J. C. Gorga, L. J. Stern, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1993. The three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33.
20. Collins, D. S., E. R. Unanue, and C. V. Harding. 1991. Reduction of disulfide bonds within lysosomes is a key step in antigen processing. J. Immunol. 147: 4054.
21. Jensen, P. E. 1991. Reduction of disulfide bonds during antigen processing: evidence from a thiol-dependent insulin determinant. J. Exp. Med. 174:1121.
22. Jensen, P. E. 1993. Acidification and disulfide reduction can be sufficient to allow intact proteins to bind class II MHC. J. Immunol. 150:3347.
23. Allen, P. M., and E. R. Unanue. 1984. Differential requirements for antigen processing by macrophages for lysozyme-specific T cell hybridomas. J. Immunol. 132:1077.
24. Streicher, H. Z., I. J. Berkower, M. Busch, F. R. N. Gurd, and J. A. Berzofsky. 1984. Antigen conformation determines processing requirements for T-cell activation. Proc. Natl. Acad. Sci. USA 81:6831.
25. Lee, P., G. R. Matsueda, and P. M. Allen. 1988. T cell recognition of fibrinogen: a determinant on the Aa-chain does not require processing. J. Immunol. 140: 1063.
26. Sette, A., L. Adorini, S. M. Colon, S. Buus, and H. M. Grey. 1989. Capacity of intact proteins to bind to MHC class II molecules. J. Immunol. 143:1265.
27. Lindner, R., and E. R. Unanue. 1996. Distinct antigen MHC class II complexes generated by separate processing pathways. EMBO J. 15:6910.
28. Shastri, N., G. Gammon, S. Horvath, A. Miller, and E. E. Sercarz. 1986. The choice between two distinct T cell determinants within a 23-amino acid region of lysozyme depends on their structural context. J. Immunol. 137:911.
29. Donermeyer, D. L., and P. M. Allen. 1989. Binding to Ia protects an immunogenic peptide from proteolytic degradation. J. Immunol. 142:1063.
30. Mouritsen, S., M. Meldal, O. Werdelin, A. S. Hansen, and S. Buus. 1992. MHC molecules protect T cell epitopes against proteolytic destruction. J. Immunol. 149:1987.
31. Deng, H., R. Apple, M. Clare-Salzler, S. Trembleau, D. Mathis, L. Adorini, and E. Sercarz. 1993. Determinant capture as a possible mechanism of protection afforded by major hixtocompatibility complex class II molecules in autoimmune disease. J. Exp. Med. 178:1675.
32. Luster, A. D., R. L. Weinshank, R. Feinman, and J. V. Ravetch. 1988. Molecular and biochemical characterization of a novel γ-interleron-mducible protein. J. Biol. Chem. 263:12036.
33. Chicz, R. M., R. G. Urban, J. C. Gorga, D. A. A. Vignali, W. S. Lane, and J. L. Strominger. 1993. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178:27.
34. Newcomb, J. R., and P. Cresswell. 1993. Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated αβ dimers. J. Immunol. 150:499.
35. Mellins, E., P. Cameron, M. Amaya, S. Goodman, D. Pious, L. Smith, and L. Arp. 1994. A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides. J. Exp. Med. 179:541.
36. Riberdy, J. M., and P. Cresswell. 1992. The antigen-processing mutant T2 suggests a role for MHC-linked genes in class II antigen presentation. J. Immunol. 148:2586.
37. Green, N., H. Alexander, A. Olson, S. Alexander, T. M. Shinnick, J. G. Sutcliffe, and R. L. Lemer. 1982. Immunogenic structure of the influenza virus hemagglutinin. Cell 28:477.
38. Guy, K., V. van Heyningen, B. B. Cohen, D. L. Deane, and C. M. Steel. 1982. Differential expression and serologically distinct subpopulations of human Ia antigens detected with monoclonal antibodies to Ia alpha and beta chains. Eur. J. Immunol. 12:942.
39. Radka, S. F., C. E. Machamer, and P. Cress well. 1984. Analysis of monoclonal antibodies reactive with human class II beta chains by two-dimensional electrophoresis and Western blotting. Hum. Immunol. 10:177.
40. Clark, E. A., and T. Yakoshi, 1984. Leukocyte Typing. A. Bernard, L. Baunsell, J. Dausset, and S. Schlossman, eds. Springer, Heidelberg, p. 195.
41. Roche, P. A., M. S. Marks, and P. Cresswell. 1991. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature 354:392.
42. Marks, M. S., J. S. Blum, and P. Cresswell. 1990. Invariant chain trimers are sequestered in the rough endoplasmic reticulum in the absence of association with HLA class II antigens. J. Cell Biol. 111:839.
43. Denzin, L. K., N. F. Robbins, C. Carboy-Newcomb, and P. Cresswell. 1994. Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells, Immunity 1:595.
44. Griffiths, G., B. Hotlack, K. Simons, I. Mellman, and S. Kornfeld. 1988. The mannose 6-phosphate receptor and the biogenesis of lysosomes. Cell 52:329.
45. Drickamer, K. 1981. Complete amino acid sequence of a membrane receptor for glycoproteins: sequence of the chick hepatic lectin. J. Biol. Chem. 256:5827.
46. Arunachalam, B., C. A. Lamb, and P. Cresswell. 1994. Transport properties of free and MHC class II-associated oligomers containing different isoforms of human invariant chain. Int. Immunol. 6:439.
47. Arunachalam, B., and P. Cresswell. 1995. Molecular requirements for the interaction of class II MHC molecules and invariant chain with calnexin. J. Biol. Chem. 270:2784.
48. Machamer, C. E., and P. Cresswell. 1982. Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens. J. Immunol. 129:2564.
49. Robbins, N. F., C. Hammond, L. K. Denzin, M. Pan, and P. Cresswell. 1996. Trafficking of major histocompatibility complex class II molecules through intracellular compartments containing HLA-DM, Hum. Immunol. 45:13.
50. Hasilik, A. 1992. The early and late processing of lysosomal enzymes: proteolysis and compartmentation, Experientia 48:130.
51. Blum, J. S., and P. Cresswell. 1988. Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc. Natl. Acad. Sci. USA 85: 3975.
52. Neefjes, J. J., and H. L. Ploegh. 1992. Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS-resistant αβ heterodimers in endosomes. EMBO J. 11:411.
53. Newcomb, J. R., C. Carboy-Newcomb, and P. Cresswell. 1996. Trimeric interactions of the invariant chain and its association with MHC class II αβ dimers. J. Biol. Chem. 271:24249.
54. Nowell, J., and V. Quaranta. 1985. Chloroquine affects biosynthesis of Ia molecules by inhibiting dissociation of invariant (gamma) chains from alpha-beta dimers in B cells. J. Exp. Med. 162:1371.
55. Lombard-Platlet, S., P. Bertolino, H. Deng, D. Gerlier, and C. Rabourdin-Combe. 1993. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell. Immunology 80:566.
56. Momburg, F., S. Fuchs, J. Drexler, R. Busch, M. Post, G. J. Hammerling, and L. Adorini. 1993. Epitope-specific enhancement of antigen presentation by invariant chain. J. Exp. Med. 178:1453.
57. Germain, R. N., and L. R. Hendrix. 1991. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353:134.
58. Vergelli, M., V. Pinet, A. B. Vogt, M. Kalbus, M. Malnari, P. Riccio, E. O. Long, and R. Martin. 1997. HLA-DR-restricted presentation of purified myelin basic protein is independent of intracellular processing. Eur. J. Immunol. 27:941.
59. Runnels, H. A., D. A. Weber, J. C. Moore, L. E. Westerman, and P. E. Jensen. 1997. Intact proteins can bind to class II histocompatibility molecules with high affinity. Mol. Immunol. 34:471.
60. Kornfeld, S., and I. Mellman. 1989. The biogenesis of lysosomes. Annu. Rev. Cell Biol. 5:483.
61. Germain, R. N., and D. H. Margulies. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:403.
62. Wolf, P. R., and H. L. Ploegh. 1995. How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu. Rev. Cell. Dev. Biol. 11:267.
63. Roche, P. A. 1995. HLA-DM: an in vivo facilitator of MHC class II peptide loading. Immunity 3:259.
64. anderson, M. S., K. Swier, L. Arneson, and J. Miller. 1993. Enhanced antigen presentation in the absence of the invariant chain endosomal localization signal. J. Exp. Med. 178:1959.